Portfolio 2 Investments
Tubulis
biotechnology, oncology, antibody-drug conjugates, healthcare
series-c
€308 M
Oct 2025
Investor
Standing Ovation
biotechnology, foodtech, precision fermentation, alternative protein, circular economy
series-b
€30 M
Mar 2026
Investor